341889372	341889372	CD	B-NP	O
|	|	NNP	I-NP	O
WSHC	WSHC	NNP	I-NP	O
|	|	VBD	B-VP	O
20635382	20635382	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1999888	1999888	CD	B-NP	O
|	|	CC	I-NP	O
11/20/2005	11/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NEW	NEW	NNP	I-NP	I-protein
LEFT	LEFT	NNP	I-NP	I-protein
BUNDLE	BUNDLE	NNP	I-NP	I-protein
BRANCH	BRANCH	NNP	I-NP	I-protein
BLOCK	BLOCK	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/12/2005	8/12/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
GOETZE	GOETZE	NNP	B-NP	O
,	,	,	O	O
BURTON	BURTON	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
BIRTH	BIRTH	NNP	I-NP	O
:	:	:	O	O
3/23/1927	3/23/1927	CD	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Hypovolemia	Hypovolemia	NN	B-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

ASSOCIATED	ASSOCIATED	VBN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
between	between	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Weakness	Weakness	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
78-year-old	78-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
silent	silent	JJ	I-NP	O
MI	MI	NN	I-NP	O
and	and	CC	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
between	between	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
longstanding	longstanding	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
and	and	CC	O	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
took	take	VBD	B-VP	O
an	an	DT	B-NP	O
extra	extra	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
fluid	fluid	JJ	B-NP	O
overloade	overloade	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
resuscitation	resuscitation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
silent	silent	JJ	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
previously	previously	RB	B-VP	O
reported	report	VBN	I-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
25	25	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Valium	Valium	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Accupril	Accupril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
Aleve	Aleve	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNP	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
causes	cause	VBZ	B-VP	O
rash	rash	NN	B-NP	O
and	and	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
causes	cause	VBZ	B-VP	O
hallucinations	hallucination	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
Irish	Irish	JJ	I-NP	O
descendent	descendent	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
with	with	IN	B-PP	O
many	many	JJ	B-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

Drinks	Drink	VBZ	B-VP	O
occasional	occasional	JJ	B-NP	O
ethanol	ethanol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
illicit	illicit	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
retired	retire	VBN	I-VP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
95.6	95.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
112	112	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
153/90	153/90	CD	I-NP	O
with	with	IN	B-PP	O
orthostasis	orthostasis	NN	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	NN	B-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
motor	motor	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Dry	Dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Tachycardic	Tachycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
premature	premature	JJ	I-NP	O
heartbeats	heartbeat	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Nondistended	Nondistended	JJ	B-ADJP	O
,	,	,	I-ADJP	O
soft	soft	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
clubbing	clubbing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
cyanosis	cyanosis	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
oriented	orient	VBN	I-VP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
III	III	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Strength	Strength	NNP	B-NP	O
is	be	VBZ	B-VP	O
5/5	5/5	CD	B-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
sensation	sensation	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
resuscitated	resuscitate	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
looking	look	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
151	151	CD	B-NP	O
pounds	pound	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
close	close	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
reportedly	reportedly	RB	B-ADVP	O
149	149	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
8/18/05	8/18/05	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
so	so	RB	B-SBAR	O
that	that	IN	I-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
stay	stay	VB	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
20mg	20mg	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
p.o.	p.o.	FW	I-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
settled	settle	VBN	I-VP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
captopril	captopril	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
9/19/05	9/19/05	CD	I-NP	O
at	at	IN	B-PP	O
6.25	6.25	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
that	that	IN	B-SBAR	O
dose	dose	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Accupril	Accupril	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
11/9/05	11/9/05	CD	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
possible	possible	JJ	B-NP	O
vegetation	vegetation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
verus	verus	IN	B-PP	O
a	a	DT	B-NP	O
flail	flail	NN	I-NP	O
leaflet	leaflet	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
vegetation	vegetation	NN	I-NP	O
raised	raise	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
temperature	temperature	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
developing	develop	VBG	I-VP	O
sepsis	sepsis	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
nothing	nothing	NN	I-NP	O
grew	grow	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
echo	echo	JJ	I-NP	O
result	result	NN	I-NP	O
required	require	VBD	B-VP	O
further	further	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
and	and	CC	O	O
suspected	suspect	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
represented	represent	VBD	B-VP	O
a	a	DT	B-NP	O
flail	flail	NN	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
leaflet	leaflet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
troponin	troponin	NN	I-NP	B-protein
One	One	CD	I-NP	I-protein
troponin	troponin	NN	I-NP	I-protein
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
0.11	0.11	CD	B-NP	O
initially	initially	RB	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
another	another	DT	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	set	VBG	I-NP	O
ARF	ARF	NN	I-NP	B-protein
and	and	CC	O	O
acute	acute	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
stress	stress	NN	I-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Laketon	Laketon	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
so	so	IN	O	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
stress	stress	NN	I-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
pursued	pursue	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
switched	switch	VBD	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
statin	statin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
LFT	LFT	NN	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
below	below	IN	B-PP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
NSVT	NSVT	NN	I-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
readdressed	readdresse	VBN	I-VP	O
in	in	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
placing	place	VBG	B-VP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
him	him	PRP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI/renal	GI/renal	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
new	new	JJ	B-NP	O
confusion	confusion	NN	I-NP	O
and	and	CC	I-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
on	on	IN	B-PP	O
morning	morning	NN	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thousands	thousand	NNS	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
and	and	CC	I-NP	O
acidemia	acidemia	NN	I-NP	O
with	with	IN	B-PP	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
WBC	WBC	NN	I-NP	O
9	9	CD	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
broad	broad	JJ	B-NP	O
spectrum	spectrum	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
including	include	VBG	B-PP	O
coverage	coverage	NN	B-NP	O
for	for	IN	B-PP	O
bartonella	bartonella	NN	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
many	many	JJ	B-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
mucomyst	mucomyst	NN	B-NP	O
and	and	CC	I-NP	O
acyclovir	acyclovir	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
GI	GI	NN	B-NP	O
in	in	IN	B-SBAR	O
case	case	NN	O	O
his	his	PRP$	B-NP	O
LFT	LFT	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
were	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
tylenol	tylenol	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
or	or	CC	I-NP	O
HSV	HSV	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
a	a	DT	B-NP	O
liver	liver	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
cancelled	cancel	VBN	I-VP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
normalize	normalize	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
RUQ	RUQ	NN	I-NP	B-protein
with	with	IN	B-PP	O
dopplers	doppler	NNS	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	I-VP	O
identified	identify	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
once	once	RB	B-ADVP	O
his	his	PRP$	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
though	though	IN	B-SBAR	O
he	he	PRP	B-NP	O
could	could	MD	B-VP	O
of	of	IN	I-VP	O
had	have	VBD	I-VP	O
shock	shock	NN	B-NP	O
liver	liver	NN	I-NP	O
but	but	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
tylenol	tylenol	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
hep	hep	NN	I-NP	O
seriologies	seriology	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
had	have	VBD	B-VP	O
all	all	DT	O	O
normalized	normalize	VBN	B-VP	O
by	by	IN	B-PP	O
admission	admission	NN	B-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
still	still	RB	I-VP	O
trending	trend	VBG	I-VP	O
downward	downward	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
low	low	JJ	B-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	I-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
vegetation	vegetation	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
consideration	consideration	NN	B-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
and	and	CC	I-NP	O
sepsis	sepsis	NN	I-NP	O
although	although	IN	B-SBAR	O
that	that	DT	O	O
never	never	RB	B-ADVP	O
panned	pan	VBN	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
feeding	feed	VBG	B-VP	O
stray	stray	NN	B-NP	O
cats	cat	NNS	I-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
bartonella	bartonella	NN	B-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
take	take	VBP	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
while	while	IN	B-SBAR	O
awaiting	await	VBG	B-VP	O
cultures	culture	NNS	B-NP	O
but	but	CC	O	O
those	those	DT	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
8/18/05	8/18/05	CD	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
microbiology	microbiology	NN	I-NP	O
data	data	NN	I-NP	O
remains	remain	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	I-NP	O
abdomen	abdoman	NNS	I-NP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
ground	ground	NN	B-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
CT	CT	NN	I-NP	O
chest	chest	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
reviewed	review	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
radiologist	radiologist	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Early	Early	RB	B-ADVP	O
on	on	IN	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
tachypnea	tachypnea	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
positional	positional	JJ	I-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
verbal	verbal	JJ	B-NP	O
consolation	consolation	NN	I-NP	O
and	and	CC	I-NP	O
redirection	redirection	NN	I-NP	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
associated	associate	VBN	I-NP	O
desaturation	desaturation	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	O	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
that	that	WDT	B-NP	O
prompted	prompt	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
psychiatric	psychiatric	JJ	B-NP	O
consultation	consultation	NN	I-NP	O
or	or	CC	O	O
social	social	JJ	B-NP	O
work	work	NN	I-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Valium	Valium	NN	I-NP	O
had	have	VBD	B-VP	O
initially	initially	RB	I-VP	O
been	be	VBN	I-VP	O
initiated	initiate	VBN	I-VP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
anxiety	anxiety	NN	I-NP	O
attacks	attack	NNS	I-NP	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
dementia	dementia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
delirium	delirium	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
transaminitis	transaminitis	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Musculoskeletal	Musculoskeletal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
of	of	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
ambulating	ambulate	VBG	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
who	who	WP	B-NP	O
did	do	VBD	B-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
further	further	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
planning	plan	VBG	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
including	include	VBG	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
had	have	VBD	B-VP	O
taken	take	VBN	I-VP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
and	and	CC	I-NP	O
steady	steady	JJ	I-NP	O
decline	decline	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
heparin/Lovenox	heparin/Lovenox	NN	B-NP	B-DNA
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
represent	represent	VB	I-VP	O
heparin	heparin	NN	B-NP	O
induced	induced	JJ	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
all	all	DT	B-NP	O
heparin	heparin	NN	I-NP	B-protein
products	product	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
lepirudin	lepirudin	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
chosen	choose	VBN	I-VP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
Argatroban	Argatroban	NNP	B-NP	O
because	because	IN	B-SBAR	O
Argatroban	Argatroban	NNP	B-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
by	by	IN	B-PP	O
liver	liver	NN	B-NP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
PF4	PF4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
bordeline	bordeline	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
laber	laber	NN	I-NP	O
later	later	RB	B-ADVP	O
changed	change	VBD	B-VP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
discrepancy	discrepancy	NN	I-NP	O
another	another	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
borderline	borderline	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
hematology	hematology	NN	I-NP	O
consult	consult	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
borderline	borderline	JJ	I-NP	O
positive	positive	JJ	I-NP	O
PF4	PF4	NN	I-NP	B-protein
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
prophylactic	prophylactic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
refrain	refrain	VB	I-VP	O
from	from	IN	B-PP	O
heparin	heparin	NN	B-NP	B-protein
products	product	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
PF4	PF4	NN	I-NP	O
in	in	IN	B-PP	O
checked	check	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Accupril	Accupril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
sodium	sodium	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
supervision	supervision	NN	B-NP	O
and	and	CC	O	O
advised	advise	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapist	therapist	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Dougall	Dougall	NNP	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
new	new	JJ	I-NP	O
PCP	PCP	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
GHAM	GHAM	NNP	I-NP	O
MILL	MILL	NNP	I-NP	O
RIDOWN	RIDOWN	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Atl	Atl	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
3/23/05	3/23/05	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alquisira	Alquisira	NNP	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
from	from	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
10/21/05	10/21/05	CD	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNP	I-NP	O
:	:	:	O	O
Do	Do	NNP	B-NP	O
not	not	RB	O	O
take	take	VB	B-VP	O
Valium	Valium	NN	B-NP	O
or	or	CC	I-NP	O
Lipitor	Lipitor	NN	I-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
cleared	clear	VBN	I-VP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
so	so	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
liver	liver	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
keep	keep	VB	B-VP	O
a	a	DT	B-NP	O
record	record	NN	I-NP	O
and	and	CC	O	O
bring	bring	VB	B-VP	O
that	that	DT	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
light	light	JJ	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
concerned	concerned	JJ	B-ADJP	O
about	about	IN	B-PP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Pi	Pi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	B-protein
90	90	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
18	18	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
103	103	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
159	159	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
54	54	CD	I-NP	I-DNA
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
118	118	CD	I-NP	O
,	,	,	O	O
bilirubin	bilirubin	NN	B-NP	O
total	total	NN	I-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.3	3.3	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.2	9.2	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
7.79	7.79	CD	B-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
14.3	14.3	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
44	44	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
199	199	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.3	1.3	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
42.2	42.2	CD	I-NP	I-protein
,	,	,	O	O
PF4	PF4	NN	B-NP	B-protein
pending	pending	NN	I-NP	O
.	.	.	O	O

Arterial	Arterial	JJ	B-NP	O
blood	blood	NN	I-NP	O
gasses	gas	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
7/9/05	7/9/05	CD	I-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
of	of	IN	B-PP	O
7.47	7.47	CD	B-NP	O
,	,	,	O	O
PO2	PO2	NN	B-NP	O
89	89	CD	I-NP	O
,	,	,	O	O
SO2	SO2	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
41	41	CD	I-NP	O
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
13.9	13.9	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
lipase	lipase	NN	B-NP	O
78	78	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
MV	MV	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
11/9/05	11/9/05	CD	I-NP	O
of	of	IN	B-PP	O
6.0	6.0	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
165	165	CD	B-NP	O
.	.	.	O	O

B12	B12	NN	B-NP	O
1704	1704	CD	I-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
14.2	14.2	CD	I-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	O
24	24	CD	I-NP	O
.	.	.	O	O

GB-IgG	GB-IgG	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
2.188	2.188	CD	I-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	O
on	on	IN	B-PP	O
6/13/05	6/13/05	CD	B-NP	O
of	of	IN	B-PP	O
0.45	0.45	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
6/13/05	6/13/05	CD	I-NP	O
of	of	IN	B-PP	O
0.13	0.13	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
on	on	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
of	of	IN	B-PP	O
0.33	0.33	CD	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
on	on	IN	B-PP	O
11/9/05	11/9/05	CD	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
on	on	IN	B-PP	O
11/9/05	11/9/05	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
0.11	0.11	CD	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
on	on	IN	B-PP	O
9/29/05	9/29/05	CD	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
and	and	CC	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
28	28	CD	B-NP	O
.	.	.	O	O

Final	Final	JJ	B-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
from	from	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

HCV	HCV	NN	B-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
615	615	CD	I-NP	O
.	.	.	O	O

RADIOLOGIC	RADIOLOGIC	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Ultrasound	Ultrasound	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
portal	portal	JJ	B-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
volumes	volume	NNS	I-NP	O
considerably	considerably	RB	B-VP	O
decreased	decrease	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
exam	exam	NN	I-NP	O
on	on	IN	B-PP	O
9/29/05	9/29/05	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
hazy	hazy	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
lung	lung	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
particularly	particularly	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
mild	mild	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
also	also	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
small	small	JJ	B-NP	O
right	right	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
is	be	VBZ	B-VP	O
again	again	RB	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
,	,	,	O	O
CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
collection	collection	NN	I-NP	O
or	or	CC	I-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
limited	limited	JJ	B-NP	O
study	study	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
right	right	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
left	leave	VBN	B-VP	O
with	with	IN	B-PP	O
subsegmental	subsegmental	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
,	,	,	O	O
presacral	presacral	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
calcification	calcification	NN	I-NP	O
.	.	.	O	O

CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
on	on	IN	B-PP	O
10/27/05	10/27/05	CD	B-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
small	small	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
volume	volume	NN	I-NP	O
ascites	ascite	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
,	,	,	O	O
nodular	nodular	JJ	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
but	but	CC	O	O
somewhat	somewhat	RB	B-ADJP	O
discrete	discrete	JJ	I-ADJP	O
,	,	,	O	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
exclude	exclude	VB	I-VP	O
septic	septic	JJ	B-NP	O
emboli	embolus	NNS	I-NP	O
but	but	CC	O	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
localized	localized	JJ	I-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
9/29/05	9/29/05	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-3204090	7-3204090	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SABO	SABO	NNP	B-NP	O
,	,	,	O	O
SYLVESTER	SYLVESTER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ZAYAS	ZAYAS	NNP	B-NP	O
,	,	,	O	O
ERICH	ERICH	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7635455	7635455	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/20/05	1/20/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/20/05	1/20/05	CD	B-NP	O

